Abstract: The present invention is related to agents capable of binding to and inhibiting or antagonizing the action of IL-11 and/or or IL-11RA for the treatment and/or prevention of abnormal uterine bleeding, which comprises heavy menstrual bleeding, prolonged bleeding, altered bleeding pattern, dysmenorrhea, as well as of the underlying diseases leiomyoma and endometriosis and the use of the agent to inhibit menstruation. Furthermore, the invention provides novel IL-11 antibodies.

Abstract: The objective of this invention is to provide ease of application for steel armored joints used in industrial concrete floor construction. It provides one step simple and precise installation. Provides a substrate for joint filler compression. Eliminates the need for wood forms and field welding that produces waste. Elevation adjustment and the ease thereof are achieved by vertical slots cut in the upright. The neoprene bolts are to be tightened when the steel is at the desired elevation. Two part armored joints separate as the concrete contracts during the curing process. Then the joint filler product is applied and retained in a permanent encased condition.